Related Experiment Videos
Transient marker stabilisation: a general procedure to construct marker-free recombinant vaccinia virus
F Scheiflinger1, F Dorner, F G Falkner
1Immuno AG, Orth/Donau, Austria.
Archives of Virology
|May 8, 1998
Summary
Researchers developed a new method to create marker-free recombinant vaccinia viruses expressing HIV-1 genes. This novel transient marker stabilization (TMS) procedure efficiently generates MVA-based vectors for potential vaccine development.
Area of Science:
- Virology and Molecular Biology
- Vaccine Development
- Immunology
Background:
- Modified Vaccinia Ankara (MVA) is a highly attenuated strain of vaccinia virus, making it a suitable candidate for vaccine vectors.
- Developing recombinant viruses that express specific antigens, such as those from Human Immunodeficiency Virus type 1 (HIV-1), is crucial for vaccine research.
- Previous methods for generating recombinant viruses often involved retaining selectable marker genes, which can complicate downstream applications.
Purpose of the Study:
- To develop and demonstrate a novel procedure for constructing marker-free recombinant vaccinia viruses.
- To generate MVA-based recombinant viruses expressing HIV-1 antigen genes (gag pol).
- To validate the efficiency of the transient marker stabilization (TMS) procedure.
Main Methods:
- Utilized a novel transient marker stabilization (TMS) procedure for generating recombinant viruses.
- Employed two selectable marker genes, Escherichia coli guanine phosphoribosyltransferase (gpt) and beta-galactosidase (lacZ), which were not retained in the final product.
- Inserted HIV-1 gag pol genes into two distinct loci of the MVA genome.
- Performed simple plaque purification steps to isolate marker-free recombinant viruses.
Main Results:
- Successfully constructed recombinant MVA viruses expressing HIV-1 gag pol genes.
- The TMS procedure effectively allowed for the generation of marker-free recombinant viruses.
- Demonstrated the efficiency of the TMS procedure by successfully inserting genes into two different MVA loci.
Conclusions:
- The transient marker stabilization (TMS) procedure is an efficient method for generating marker-free recombinant vaccinia viruses.
- This technique facilitates the production of MVA-based vectors expressing foreign antigens, such as HIV-1 genes, without residual markers.
- The developed recombinant viruses hold potential for further investigation in HIV-1 vaccine development.